This Investor Sold Million: Why Biotech Shares Stay Bullish
A prominent investor dumped a multi‑million stake in a biotech stock that’s up double digits. This article explains w...
Explore highly rated travel credit cards that come with no fees. Maximize your travel rewards while minimizing costs.
22,438 articlesA prominent investor dumped a multi‑million stake in a biotech stock that’s up double digits. This article explains w...
Oil breaks $100 again as Middle East tensions flare, lifting energy stocks and reshaping risk-on bets for 2026. Inves...
When a venerable logistics giant trades near the $120 mark, investors debate more than price. This guide weighs the u...
Zoom's post-pandemic growth trajectory remains uncertain as investors weigh AI opportunities and competition. This pi...
ECL, EMN, and BCC report mixed quarters as 2026 guidance and cost actions set the tone for a volatile chemicals secto...
Intercontinental Exchange rolls out AI-driven voice and chat agents for mortgage servicing, aiming to simplify borrow...
Bitcoin flirted with $76,000 as long-dormant coins linger. The Coin Days Destroyed Multiple hit a 2022-era low, fueli...
Medicare’s new $2,000 out-of-pocket cap on Part D drugs is delivering real relief for retirees, with insulin costs ca...
DocuSign's 2026 earnings narrative centers on ARR expansion, margin discipline, and stronger cash flow in a competiti...
Oracle slipped this year, but does that mean it's a no-brainer AI buy? This practical guide weighs AI potential, fina...
NVIDIA CEO Jensen Huang predicts AI agents will infiltrate every function in every company, signaling a new phase for...
Symbotic's shiny narrative has investors buzzing, but the biggest gains often hinge on real execution, not just optim...